New drug compound to treat Alzheimer’s disease

by Medindia Content Team on  January 23, 2006 at 7:49 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

New drug compound to treat Alzheimer’s disease
Professor Martin Watterson and team from Northwestern University, Feinberg School of Medicine have found a new compound called MW01-5-188WH which has been found to inhibit the production of the immune cells Cytokines which leads to activation of glia, which is responsible for causing inflammation in brain cells leading to neuron loss leading to degeneration of brain cells in Alzheimer's disease.

Alzheimer's disease is characterized by loss in memory due to damage to brain cells which leads to loss of memory, reasoning ability and the capacity to read and understand decreases, they become increasingly forgetting, disoriented in their approach and will develop problems in solving mathematical problems. The researchers found that this compound inhibits cytokines not leading to neurodegenerative diseases in animal models and the researchers are planning to do a clinical trial on human trials which would prove the efficacy of the drug.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive